谷歌浏览器插件
订阅小程序
在清言上使用

A retrospective study on the development of osteonecrosis of the jaws (ONJ) in patients treated with bone modifying agents (BMA)

Annals of Oncology(2023)

引用 0|浏览17
暂无评分
摘要
Many patients with malignant tumors develop bone metastases which can cause skeletal related events (SREs) during their life. Bone Modifying Agents (BMA) are widely used in various types of cancer to prevent SREs. Osteonecrosis of the Jaws (ONJ) is a relatively rare but serious adverse event of BMA and can be caused by other drugs like angiogenesis inhibitors. However, its frequency and risk factors are still unknown.
更多
查看译文
关键词
osteonecrosis,bone,jaws
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要